Saturday, March 7, 2009

GENEI:THE SOLAR CONCENTRATOR COMPANY

GENEI: Licensing solar concentrator design for maximum thermal efficiency Our PPAs Prove It! Business Plan Prepared for Investors Circle March 2009 The Promise Genei‟s low-cost, high-efficiency, solar dish concentrator technology will revolutionize the solar power electrical generation industry and other industrial thermal processes using solar power.
Contact Dr. Francis C. W. Fung Chief Executive Officer GENEI, INC. 514 Arballo Drive, Suite 100 San Francisco, CA 94132-2163 francis@genei.us 415.246.6886
Confidential Disclosure2
Executive Summary
• Mission
To avoid the climate change apocalypse, Genei is poised to upgrade the design structure and reflectivity components of solar dishes so as to replace conventional power generation sources, thus dramatically reducing CO2, balancing human needs with environmental concerns, ensuring national security, and improving quality of life. By improving all solar dish companies‟ products or becoming the world‟s most efficient thermal solar dish company, Genei intends to revolutionize the solar electric marketplace.
• The Problem
World solar electricity generation lags in creating large utility-level capacity. The price point for solar electricity must match the cost of natural gas to be competitive, and eventually must be lower.
• Genei‟s Solution
Apply our proprietary know-how and five patent-pending applications in innovative dish design and reflective coating technology –– affirmed by over 30,000 patent searches. Our interlocking mirror elements are load-bearing and non-glass based, eliminating costly and heavy support superstructures and three to five year replacement cycles.
• Key Benefits
These include low cost reflective elements, high efficiency, ease of manufacturing, and a reduced cost onsite process. Attached spectral analysis by an independent laboratory shows that the reflectivity of Genei mirror elements exceeds that measured for first surface silver.
• Potential
Genie solar concentrators can be licensed by most solar utility manufacturers and developers in conjunction with Stirling engine, steam turbine, and triple junction photovoltaic for electric power generation. Examples: Starpoint Solar (our strongest strategic partner) as well as SES, Ausra, Brightstar, PG&E, and China Micropowers.
• Deployment
Immediate: 4 Units (demo site in Victorville, CA) 12-months: 1,000 Units (50 MW‟s), Palmdale, CA 3 years: 50,000 Units (2,500 MW‟s) for Inland Energy 5 years: 100,000 Units (5,000 MW‟s) 10 years: 200,000 Units (10,000 MW‟s) 3
• Management
Genei‟s management team and world-renowned scientists represent broad expertise in the energy industry, Stirling engines, reflective and protective coatings, solar dish design, mass manufacturing, marketing, and start-up through IPO experience. Genei‟s CEO has been a proponent of Stirling engine technology for over 20 years. Stirling cycle engine technology is now resurging and emerging as a commanding utility-scale solar electric component. Our Team is currently exploring partnerships with over 15 solar concentrator, thermal trough, and solar dish companies as well as pilot projects with California electrical utilities.
• Current Operations
Genei is continuing to develop advanced, low-cost reflective materials and technology-disruptive dish construction to further improve the efficiency and reduce the costs of thermal solar concentrators for various important utility and industrial applications.
• Fiscal Overview
As soon as Genei builds and presents its full-scale models, Starpoint will tender a Partnership Agreement to incorporate Genei‟s technology with theirs; a sale to Inland will ensue, and Genei will be positioned to market and cement additional licensing relationships.
• Return on Investment
R&D-based licensing company Genei will be able to repay funds within 2 years: 1/3rd after 12 months; remaining 2/3rds another 12 months, at approx 200% ROI, simple interest. Revenues are based on $0.5 million first-year licensing fee plus $100/dish; first-year revenue projected at $2.2 million, which by contract can only increase.
Dr. Francis Fung, CEO
francis@genei.us

No comments: